Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier and get daily trading ideas and historical data downloads. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Ekimas Corp (ASNB)

Ekimas Corp (ASNB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Ekimas Corp 3651 Lindell Road Suite D565 Las Vegas NV 89103 USA

www.advbiomaterials.com P: 424-256-8560

Description:

ADVANSOURCE BIOMATERIALS CORPORATION develops advanced polymer materials which provide critical characteristics in the design and development of medical devices. The Company's biomaterials are used in devices that are designed for treating a broad range of disease states and anatomical sites. AdvanSource's business model leverages its proprietary materials science technology and manufacturing expertise in order to expand its product sales and royalty and license fee income. The Company has developed CardioPass, a synthetic coronary bypass graft, which is currently in a clinical trial in Europe.

Key Statistics

Overview:

Market Capitalization, $K 4,929
Enterprise Value, $K 4,679
Shares Outstanding, K 5,799
Annual Sales, $ 0 K
Annual Net Income, $ -290 K
60-Month Beta 0.37
% of Insider Shareholders 7.80%
% of Institutional Shareholders 0.00%
Float, K 5,347
% Float 92.20%
Short Volume Ratio 1.00

Growth:

1-Year Return -41.38%
3-Year Return -90.29%
5-Year Return -59.43%
5-Year Revenue Growth -100.00%
5-Year Earnings Growth 70.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.15 on 02/14/23
Latest Earnings Date 06/27/23
Earnings Per Share ttm -1.05
EPS Growth vs. Prev Qtr -1,400.00%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%
Most Recent Split 1-50 on 03/11/22

ASNB Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -7,902.31%
Return-on-Assets % -5,274.01%
Profit Margin % 0.00%
Debt/Equity 0.00
Price/Sales N/A
Price/Cash Flow N/A
Price/Book N/A
Book Value/Share 0.00
Interest Coverage 0.00
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar